# Viðskipti stjórnenda og tengdra aðila
Canonical URL: https://biopharmsignal.com/news/ALVO/vi-skipti-stj-rnenda-og-tengdra-a-ila-53408632
Ticker: ALVO
Company: Alvotech
Source: Alvotech
Published: 2026-07-03 20:01 EST
## Summary

Í viðhengi er tvær tilkynningar sem lagðar voru inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur...

## Article Body
Í viðhengi er tvær tilkynningar sem lagðar voru inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF) varðandi viðskipti stjórnenda og tengdra aðila þar sem tilkynnt var um veðsetningu Celtic Lux Holdings S.a. r.l. (áður skráð sem Alvogen Lux Holdings S.a. r.l.) á (i) 88.940.619 hlutum í Alvotech og (ii) 7.007.321 sænskum heimildarskírteinum (ígildi hlutabréfa). Viðskiptin fóru fram þann 26. júní sl.

Alvotech Investor Relations Benedikt Stefansson, VP alvotech.ir@alvotech.com

Managers Transactions - CSSF Form - Celtic Lux Holdings S.à r.l. 2026-07-02 (i)

Managers Transactions - CSSF Form - Celtic Lux Holdings S.à r.l. 2026-07-02 (ii)
## Recent Company News
- 2026-07-03 20:01 EST — [Viðskipti stjórnenda og tengdra aðila](https://biopharmsignal.com/news/ALVO/vi-skipti-stj-rnenda-og-tengdra-a-ila-53408632) — Source: Alvotech
- 2026-07-03 20:01 EST — [Transactions of Managers and Closely Associated Persons](https://biopharmsignal.com/news/ALVO/transactions-of-managers-and-closely-associated-persons-9140a9e4) — Source: Alvotech
- 2026-07-01 08:00 EST — [Alvotech styrkir lausafjárstöðu sína enn frekar með aðgengi að 75 milljóna dala lánsfjármögnun](https://biopharmsignal.com/news/ALVO/alvotech-styrkir-lausafj-rst-u-s-na-enn-frekar-me-a-gengi-a-75-millj-na-dala-l-n-5c600a72) — Source: Alvotech
- 2026-07-01 08:00 EST — [Alvotech further strengthens liquidity by securing term loan facility of $75 million](https://biopharmsignal.com/news/ALVO/alvotech-further-strengthens-liquidity-by-securing-term-loan-facility-of-75-mill-80932cf9) — Source: Alvotech
- 2026-06-22 22:48 EST — [Viðskipti stjórnenda og tengdra aðila](https://biopharmsignal.com/news/ALVO/vi-skipti-stj-rnenda-og-tengdra-a-ila-28f847d7) — Source: Alvotech
## Related News
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)
- 2026-07-28 12:05 EST — GSK — [GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK](https://biopharmsignal.com/news/GSK/gsk-to-establish-new-flagship-r-d-centre-on-cambridge-biomedical-campus-uk-6f2bb859)